The project will encompass 1.4 million square feet across 10 buildings and boost the drugmaker’s production of the diabetes medication Ozempic…Read More
Author Archives: Rubi Klemp
Increasingly, women have reported becoming pregnant while taking Ozempic despite being on hormonal birth control.Read More
Novo Nordisk’s blockbuster diabetes and weight loss drugs Ozempic and Wegovy may have a potential link with an eye condition that causes vision loss, according to a new study published Wednesday in JAMA OphthalmologyRead more…Read More
With weight loss and diabetes drugs in high demand and short supply, potentially dangerous counterfeits have flooded the market…Read More
Public employees in West Virginia who took the drugs lost weight and were healthier, and some are despondent that the state is canceling a program to help pay for them…Read More
Novo Nordisk’s GLP-1 weight loss treatment Wegovy has been approved for use in China, opening up one of the world’s largest weight loss markets to the Danish pharma giant.Read more…Read More
Skyrocketing sales for weight loss drugs known as GLP-1s, first made popular via the diabetes treatment Ozempic, have had ripple effects across the global economy. As more companies try to adapt to — and squeeze profit from — the Ozempic craze, they’re taking distinct yet familiar approaches to market the drugs.Read more…Read More
Ozempic for type 2 diabetes April 26, 2024 – Before there was Ozempic, Wegovy, or Zepbound, there were cost-friendly, safe, and effective weight loss drugs. FDA-approved obesity medication like orlistat (brand name: Xenical), phentermine/topiramate (Qsymia), and naltrexone/bupropion extended release (Contrave) have been on the market for decades. “Some older obesity medications go all the way back to […]